Nature Communications (Feb 2022)

Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo

  • Marina Antillon,
  • Ching-I Huang,
  • Ronald E. Crump,
  • Paul E. Brown,
  • Rian Snijders,
  • Erick Mwamba Miaka,
  • Matt J. Keeling,
  • Kat S. Rock,
  • Fabrizio Tediosi

DOI
https://doi.org/10.1038/s41467-022-28598-w
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 13

Abstract

Read online

Gambiense human African trypanosomiasis has been targeted for elimination of transmission by 2030. Here, the authors assess the cost-effectiveness of elimination strategies in the Democratic Republic of the Congo and find that those which lead to elimination of transmission might also be considered cost-effective by conventional thresholds.